2026 NPPES data Pediatric Otolaryngology Physician NPI 1336553197 MD
Verify on CMS →

MARISSA SCHWARTZ, MD

Pediatric Otolaryngology Physician in LONG BEACH, California. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
523
Medicare Part D claims · 188 beneficiaries · Pediatric Otolaryngology Physician avg: 313
Generic prescribing
98%
generic claims · 2% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$133.65
5 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

MARISSA SCHWARTZ, MD filed 523 Medicare Part D claims in 2023 as a Pediatric Otolaryngology Physician in LONG BEACH, California, prescribing 98% generic.

523
Part D claims, 2023
98%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARISSA SCHWARTZ, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

523 Top 34% higher than 66% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic — not verified)

MARISSA SCHWARTZ, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MARISSA SCHWARTZ, MD?

Quality data not reported

NPI registry status

Active

Issued 06/19/2014

NPI 1336553197

Primary specialty

Pediatric Otolaryngology Physician

Niche

574 US NPIs in this specialty

Medicare Part D claims

523 67% vs specialty avg

2023 prescription claims

Specialty avg: 313

Specialty distribution in California

How Pediatric Otolaryngology Physician compares to other specialties among California providers

California providers

Pediatric Otolaryngology Physician share within California

1. Pediatric Otolaryngology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Pediatric Otolaryngology Physician share within California

Specialty board-certification context

Estimated specialty board-certified rate — Pediatric Otolaryngology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Pediatric Otolaryngology Physician ABMS/AOA estimate

Est. board-certified rate (Pediatric Otolaryngology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Pediatric Otolaryngology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARISSA SCHWARTZ, MD is a Pediatric Otolaryngology Physician provider practicing in LONG BEACH, California, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1336553197. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARISSA SCHWARTZ, MD appears in the CMS NPPES registry as a Pediatric Otolaryngology Physician provider holding MD credentials at 433 E WARDLOW RD, LONG BEACH, CA, 90807, with a listed phone of (562) 427-0550. NPI 1336553197 was issued on 06/19/2014. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what SCHWARTZ most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 523 prescription claims written by this provider, covering 188 Medicare beneficiaries and totaling roughly $13K in drug spend, split 2% brand-name and 98% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Pediatric Otolaryngology Physician is a narrow specialty nationwide, with 574 enrolled providers across 43 states and an average of 313 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

433 E WARDLOW RD
LONG BEACH, CA 90807

Provider Details

NPI 1336553197
Specialty Pediatric Otolaryngology Physician
Credentials MD
Gender Female
NPI Issued 06/19/2014

Hospital and facility affiliations

Facilities where MARISSA SCHWARTZ, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

TORRANCE HEALTH ASSOCIATION INC
TORRANCE, CA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARISSA SCHWARTZ, MD. Source: openpaymentsdata.cms.gov.

Total received

$134

Largest payer

GlaxoSmithKline, LLC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — California MBC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 — they are NOT specific to MARISSA SCHWARTZ, MD. To verify MARISSA SCHWARTZ, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

576
Total board actions, California 2023
Across 556 cases
3.84
Actions per 1,000 licensees
California statewide rate
probation
Most common action type
186 cases

MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

MARISSA SCHWARTZ, MD — brand share 2.0%
Specialty average (est.)

2% brand-name claims vs 98% generic, on 523 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

523
Total Claims
$13K
Total Drug Cost
188
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
670
Total Day Supply
17,819
Brand vs Generic
2% brand / 98% generic
Brand Drug Cost
$2K
Generic Drug Cost
$11K
Antibiotic Claims
39

Patient Demographics

Average Patient Age
73.2 years
Avg HCC Risk Score
1.57
Gender Split
66% female / 34% male
Age Distribution
<65: 14, 65-74: 105, 75-84: 50, 85+: 19

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Fluticasone Propionate
134
Azelastine Hcl
103
Ipratropium Bromide
52
Famotidine
25
Mupirocin
25
Montelukast Sodium
23
Omeprazole
20
Ofloxacin
14
Amoxicillin-Clavulanate Potass
Amoxicillin/Potassium Clav
11
Ciprofloxacin-Dexamethasone
Ciprofloxacin Hcl/Dexameth
11

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Pediatric Otolaryngology Physician Overview

How MARISSA SCHWARTZ, MD fits within the Pediatric Otolaryngology Physician landscape nationally.

574
Pediatric Otolaryngology Physician Providers in US
43
States with Pediatric Otolaryngology Physician
313
Avg Claims per Provider

MARISSA SCHWARTZ, MD's 523 claims are above the specialty average of 313.

Nearby Pediatric Otolaryngology Physician Providers in California

Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as SCHWARTZ.

Compare Pediatric Otolaryngology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARISSA SCHWARTZ, MD's specialty?
MARISSA SCHWARTZ, MD specializes in Pediatric Otolaryngology Physician and practices in LONG BEACH, California. Credentials: MD.
How much does MARISSA SCHWARTZ, MD prescribe under Medicare Part D?
In 2023, MARISSA SCHWARTZ, MD wrote 523 Medicare Part D claims totaling $13K in drug costs for 188 beneficiaries.
Where is MARISSA SCHWARTZ, MD located?
MARISSA SCHWARTZ, MD is located at 433 E WARDLOW RD, LONG BEACH, CA, 90807. Phone: (562) 427-0550.
What is MARISSA SCHWARTZ, MD's NPI number?
MARISSA SCHWARTZ, MD's National Provider Identifier (NPI) is 1336553197, issued on 06/19/2014.
Does MARISSA SCHWARTZ, MD prescribe more brand-name or generic drugs?
MARISSA SCHWARTZ, MD's prescribing is 2% brand-name and 98% generic drugs by claim count, with $2K in brand drug costs.
How many Pediatric Otolaryngology Physician providers are there in the US?
There are 574 Pediatric Otolaryngology Physician providers across 43 states in the US. The average Pediatric Otolaryngology Physician provider writes 313 Medicare Part D claims per year.
What drugs does MARISSA SCHWARTZ, MD prescribe most often?
Based on 2023 Medicare Part D data, MARISSA SCHWARTZ, MD's most frequently prescribed drugs include Fluticasone Propionate, Azelastine Hcl, Ipratropium Bromide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARISSA SCHWARTZ, MD accept Medicare?
MARISSA SCHWARTZ, MD appears in CMS Medicare data with 523 Part D claims and 188 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARISSA SCHWARTZ, MD's credentials?
MARISSA SCHWARTZ, MD's NPI is 1336553197 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology